Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:24 AM
Ignite Modification Date:
2025-12-25 @ 1:24 AM
NCT ID:
NCT02004093
Eligibility Criteria:
Inclusion Criteria:
* histologically confirmed ovarian, primary peritoneal, or fallopian tube cancer;
* only 1 previous regimen, which must be platinum-based;
* platinum-sensitive disease which is defined by a progression-free interval of greater than 6 months after completion of platinum-based chemotherapy.
Exclusion Criteria:
* previous radiotherapy;
* previous treatment with an anti-cancer vaccine or any targeted therapy;
* major surgery or traumatic injury within 4 weeks of study;
* history or evidence of central nervous system metastases.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT02004093
Study Brief:
Protocol Section:
NCT02004093